Clinical Trial Highlights

• Recent Data from LEAD
• Complications of Diabetes Have a Significant Long-Term Impact on QoL
• The Lifetime Risk of Nephropathy and Its Progression May Be Greater than Previously Reported
• The Association between Arterial Stiffness and LV Diastolic Function in T2DM: 8-Year Follow-up to the Hoorn Study
• BNP is a Predictor of Changes in LV Systolic and Diastolic Function Regardless of Diabetes Status
• An Update on the DIGAMI Studies
• ADDITION Shows No Increased Benefit of Early Multifactorial Intensive Therapy
• Early Treatment with Olmesartan Delays Progression of Nephropathy in Patients with Type 2 Diabetes
• Candesartan Fails to Prevent Microalbuminuria in Hypertensive Diabetics When Stringent Criteria are Used